EDGAR Filing Documents for 0001564590-18-022747

Form 8-K - Current report:

SEC Accession No. 0001564590-18-022747

Filing Date

2018-09-06

Accepted

2018-09-06 15:45:37

Documents

Period of Report

2018-09-06

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K INVESTOR PRESENTATION	atrs-8k_20180906.htm	8-K	32896
2	EX-99.1 INVESTOR PRESENTATION	atrs-ex991_6.htm	EX-99.1	26333
3	GRAPHIC	g5ir0dmtlwf3000013.jpg	GRAPHIC	322727
4	GRAPHIC	g5ir0dmtlwf3000016.jpg	GRAPHIC	225407
5	GRAPHIC	g5ir0dmtlwf3000009.jpg	GRAPHIC	376457
6	GRAPHIC	g5ir0dmtlwf3000019.jpg	GRAPHIC	297673
7	GRAPHIC	g5ir0dmtlwf3000015.jpg	GRAPHIC	223491
8	GRAPHIC	g5ir0dmtlwf3000022.jpg	GRAPHIC	250714
9	GRAPHIC	g5ir0dmtlwf3000018.jpg	GRAPHIC	289789
10	GRAPHIC	g5ir0dmtlwf3000012.jpg	GRAPHIC	237249
11	GRAPHIC	g5ir0dmtlwf3000020.jpg	GRAPHIC	147241
12	GRAPHIC	g5ir0dmtlwf3000005.jpg	GRAPHIC	320716
13	GRAPHIC	g5ir0dmtlwf3000025.jpg	GRAPHIC	271533
14	GRAPHIC	g5ir0dmtlwf3000023.jpg	GRAPHIC	113752
15	GRAPHIC	g5ir0dmtlwf3000001.jpg	GRAPHIC	252588
16	GRAPHIC	g5ir0dmtlwf3000007.jpg	GRAPHIC	205363
17	GRAPHIC	g5ir0dmtlwf3000021.jpg	GRAPHIC	244206
18	GRAPHIC	g5ir0dmtlwf3000014.jpg	GRAPHIC	267481
19	GRAPHIC	g5ir0dmtlwf3000017.jpg	GRAPHIC	548479
20	GRAPHIC	g5ir0dmtlwf3000002.jpg	GRAPHIC	600008
21	GRAPHIC	g5ir0dmtlwf3000006.jpg	GRAPHIC	243133
22	GRAPHIC	g5ir0dmtlwf3000024.jpg	GRAPHIC	459230
23	GRAPHIC	g5ir0dmtlwf3000008.jpg	GRAPHIC	281516
24	GRAPHIC	g5ir0dmtlwf3000026.jpg	GRAPHIC	431413
25	GRAPHIC	g5ir0dmtlwf3000010.jpg	GRAPHIC	258619
26	GRAPHIC	g5ir0dmtlwf3000004.jpg	GRAPHIC	226657
27	GRAPHIC	g5ir0dmtlwf3000003.jpg	GRAPHIC	272581
28	GRAPHIC	g5ir0dmtlwf3000011.jpg	GRAPHIC	244086
	Complete submission text file	0001564590-18-022747.txt		10546905

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628

Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)